It is well recognized that the lowering of low-density lipoprotein (LDL) cholesterol can
substantially reduce coronary artery disease (CAD)–related morbidity and mortality. The …

High-density lipoprotein-cholesterol (HDL-C) is a continuous inverse cardiovascular risk
factor. The mechanisms by which HDLs protect against atherosclerosis are multiple. The …

High-density lipoproteins (HDLs) have multiple pleiotropic effects against arteriosclerosis.
Most are independent of the cholesterol mass within HDL particles. Yet, HDL cholesterol …

The field of cardiovascular prevention has long anticipated the evolution of high-density
lipoprotein (HDL) therapy from unproven metabolic tweaking to pillar of risk reduction on par …

Although High Density Lipoprotein Cholesterol (HDL-C) levels are inversely proportional to
cardiovascular risk in many studies, recent pharmacological interventional studies with HDL …

High-density lipoprotein cholesterol (HDL-C) has been identified as an independent inverse
predictor of coronary heart disease, leading to the inclusion of HDL-C in certain risk engines …

Atherosclerosis is one of the most common causes of death and disability in the United
States today despite the availability of statins, which reduce hyperlipidemia, a risk factor that …

Abstract Purpose of Review This review aims to summarize and discuss the recent findings
in the field of using HDL mimetics for the treatment of patients with coronary artery disease …

Plasma levels of high density lipoprotein (HDL) cholesterol levels and of apolipoprotein AI
are inversely correlated with the incidence of coronary heart disease. According to the HDL …

Low serum levels of high-density lipoprotein cholesterol (HDL-C) are highly prevalent and
are recognized as an independent risk factor for cardiovascular morbidity (myocardial …